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InvIted Commentary
Psychosocial treatments for Clinical High risk Individuals
Jean addington and mark van der Gaag
McFarlane and colleagues present an integrated approach 
to pre-psychosis and first episode psychosis patients. It 
is critical to distinguish between these 2 groups and to 
establish evidence-based treatments. This commentary 
focuses on clinical high risk (CHR) in the pre-psychosis 
time frame.
 • The goal of treatment for those at CHR is not just on 
preventing conversion to psychosis but ameliorating the 
wide range of problems with which these young people 
present.1 The majority of these CHR individuals are 
indeed clinical cases. Not only are they troubled by the 
attenuated psychotic symptoms which define their “at 
risk state” but the majority have comorbid diagnoses 
in particular depression and anxiety. Substance use, 
in particular cannabis and alcohol use, is not uncom-
mon and there is well-supported evidence of their poor 
social skills and difficulty with relationships that con-
tinue even when there is an improvement in the attenu-
ated psychotic symptoms.2
 • At this early stage anti-psychotic medication may have 
a poor risk/benefit profile and currently psychosocial 
treatments are the treatments of choice. Already several 
reviews and/or meta-analyses of RCTs3,4 support the 
benefits of psychosocial treatments. Cognitive behavior 
therapy (CBT), the most often studied therapy, may pre-
vent the transition to psychosis (1) in that it can enhance 
non-psychotic explanations for the odd experiences of 
those at CHR. It has demonstrated improvement in 
attenuated psychotic symptoms, and could be helpful 
for anxiety and depression. CBT thus has become an 
evidence-based treatment option in recent years and 
meta-analysis showed in 676 patients that conversions 
to psychosis can be reduced in about 50%.4,5
 • There is a need for more work in psychosocial treat-
ments to help the CHR individual with social relations 
and maintaining strong family connection/support. 
Withdrawal and loneliness prevent the testing of ideas 
and hypotheses about other people and may contribute 
to the development of psychosis. Reality is in the end 
a social construction. To stay in touch with reality is to 
stay in touch with other people. The MacFarlane study 
demonstrates the importance of family members to stay 
involved with CHR youth and to keep them on track in 
a shared reality. Although the evidence is indirect and 
not as convincing as the results of a randomized con-
trolled design, the findings hint to outreach to families, 
schools, and workplaces to prevent social exclusion in 
the CHR population. The only RCT specifically with 
family interventions confirmed that improving family 
relationships may have prophylactic efficacy in individ-
uals at high risk for psychosis.6
 • The next steps should be in defining treatments that 
meet the specific needs of CHR youth; in particular 
efforts to prevent social withdrawal; that is from friends, 
school, or workplace. One treatment does not fit all; 
thus treatments need to fit the needs of the individual, 
their presenting problems, and their unique level of risk 
of developing a psychotic illness as well as different 
resiliency factors that may need to be supported.
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